Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Oct;50(4):545–547. doi: 10.1038/bjc.1984.214

Enhancement by serotonin of intra-tumour penetration of spleen cells.

G Lespinats, M Bonnet, S Tlouzeau, C Burtin
PMCID: PMC1976885  PMID: 6487522

Full text

PDF
545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askenase P. W., Metzler C. M., Gershon R. K. Localization of leucocytes in sites of delayed-type hypersensitivity and in lymph nodes: dependence on vasoactive amines. Immunology. 1982 Oct;47(2):239–246. [PMC free article] [PubMed] [Google Scholar]
  2. Burtin C., Scheinmann P., Salomon J. C., Lespinats G., Canu P. Decrease in tumour growth by injections of histamine or serotonin in fibrosarcoma-bearing mice: influence of H1 and H2 histamine receptors. Br J Cancer. 1982 Jan;45(1):54–60. doi: 10.1038/bjc.1982.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Denekamp J., Hobson B. Endothelial-cell proliferation in experimental tumours. Br J Cancer. 1982 Nov;46(5):711–720. doi: 10.1038/bjc.1982.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Farram E., Nelson D. S. Mouse mast cells as anti-tumor effector cells. Cell Immunol. 1980 Oct;55(2):294–301. doi: 10.1016/0008-8749(80)90162-8. [DOI] [PubMed] [Google Scholar]
  5. Ford W. L. Lymphocyte migration and immune responses. Prog Allergy. 1975;19:1–59. doi: 10.1159/000313381. [DOI] [PubMed] [Google Scholar]
  6. Galoppin L., Raynaud F., Ponvert C., Fray A., Scheinmann P., Lespinats G., Canu P., Burtin C. Tissue histamine levels and mast cell numbers in tumour-bearing mice. Agents Actions. 1984 Apr;14(3-4):494–496. doi: 10.1007/BF01973857. [DOI] [PubMed] [Google Scholar]
  7. Gershon R. K., Askenase P. W., Gershon M. D. Requirement for vasoactive amines for production of delayed-type hypersensitvity skin reactions. J Exp Med. 1975 Sep 1;142(3):732–747. doi: 10.1084/jem.142.3.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karlsson L., Alpsten A., Mattsson J., Peterson H. I. Influence of vasoactive drugs on the intratumor distribution of blood flow and vascular volume in a transplantable rat fibrosarcoma. J Cancer Res Clin Oncol. 1983;105(3):212–220. doi: 10.1007/BF00395748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Karlsson L., Alpsten M., Appelgren K. L., Peterson H. I. Intratumor distribution of blood flow and of vascular volume in a transplantable rat sarcoma. J Cancer Res Clin Oncol. 1980;98(3):213–219. doi: 10.1007/BF00410785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Klein E., Vánky F., Galili U., Vose B. M., Fopp M. Separation and characteristics of tumor-infiltrating lymphocytes in man. Contemp Top Immunobiol. 1980;10:79–107. doi: 10.1007/978-1-4684-3677-8_4. [DOI] [PubMed] [Google Scholar]
  11. Lynch N. R., Salomon J. C. Passive local anaphylaxis: demonstration of antitumor activity and complementation of intratumor BCG. J Natl Cancer Inst. 1977 Apr;58(4):1093–1098. doi: 10.1093/jnci/58.4.1093. [DOI] [PubMed] [Google Scholar]
  12. Mattsson J., Alpsten M., Appelgren L., Peterson H. I. Influence of noradrenaline on local tumour blood flow. Eur J Cancer. 1980 Jan;16(1):99–102. doi: 10.1016/0014-2964(80)90114-0. [DOI] [PubMed] [Google Scholar]
  13. Mattsson J., Lilja J., Peterson H. I. Influence of vasoactive drugs on local tumor blood flow. Eur J Cancer Clin Oncol. 1982 Jul;18(7):677–684. doi: 10.1016/0277-5379(82)90214-0. [DOI] [PubMed] [Google Scholar]
  14. Schwartz A., Askenase P. W., Gershon R. K. The effect of locally injected vasoactive amines on the elicitation of delayed-type hypersensitivity. J Immunol. 1977 Jan;118(1):159–165. [PubMed] [Google Scholar]
  15. Shubik P. Vascularization of tumors: a review. J Cancer Res Clin Oncol. 1982;103(3):211–226. doi: 10.1007/BF00409698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Suzuki M., Hori K., Abe I., Saito S., Sato H. A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst. 1981 Sep;67(3):663–669. [PubMed] [Google Scholar]
  17. Van Nueten J. M. 5-hydroxytryptamine and precapillary vessels. Fed Proc. 1983 Feb;42(2):223–227. [PubMed] [Google Scholar]
  18. Young S. W., Muller H. H., Marincek B. Response of neoplastic and normal vasculature to acetylcholine. Eur J Cancer Clin Oncol. 1983 Mar;19(3):383–387. doi: 10.1016/0277-5379(83)90137-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES